Status:
COMPLETED
Vaso-inotropic Score and ECMO-VA Support in Post-cardiotomy Cardiogenic Shock.
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
EMCO-VA
Eligibility:
All Genders
18+ years
Brief Summary
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is a well-established lifesaving treatment for refractory cardiogenic shock, with or without concomitant respiratory failure. VA-ECMO is usu...
Eligibility Criteria
Inclusion
- age over 18 years
- Cardiac surgery with cardiopulmonary bypass
- Post cardiotomy cardiogenic shock
- ECMO-VA implanted in OR
Exclusion
- LVAD
- Heart transplantation
- Incomplete data in relation to outcomes
- Cardiac arrest
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
2769 Patients enrolled
Trial Details
Trial ID
NCT05412303
Start Date
January 1 2019
End Date
December 31 2021
Last Update
June 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Dijon Bourogne
Dijon, France, 21000